Related Experiment Videos
Characterization of a microdissection library from human chromosome region 3p14
W Bardenheuer1, S Szymanski, A Lux
1Department of Medical Oncology (Cancer Research), University of Essen Medical School, Federal Republic of Germany.
Genomics
|January 15, 1994
Summary
Researchers identified new chromosome breakpoints in 3p14-p23, crucial for understanding tumor suppressor genes in cancers like lung and kidney cancer. This work aids in isolating genes involved in neoplasm development.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Alterations in human chromosome 3p14-p23 are implicated in various cancers, potentially due to tumor suppressor gene inactivation.
- Identifying these genes is critical for understanding cancer pathogenesis.
Purpose of the Study:
- To isolate and characterize novel tumor suppressor genes within the 3p14-p23 region.
- To refine mapping of this chromosomal region and identify new breakpoints.
Main Methods:
- Construction and screening of a microdissection library specific for human chromosome 3p14.
- Isolation and characterization of recombinant clones, focusing on unique single-copy DNA sequences.
- Mapping of DNA sequences using a human-rodent cell hybrid mapping panel.
Main Results:
- 428 recombinant clones were analyzed, yielding 96 human single-copy DNA sequences, with 57 unique clones.
- Forty-four unique clones were mapped to the microdissected region.
- Four probes identified two new chromosome breakpoints in 3p14.2, distinct from the hereditary renal cell carcinoma translocation breakpoint.
- One probe mapped to a homozygously deleted region in a small cell lung cancer cell line (U2020).
- Microdissection clones proved effective for isolating yeast artificial chromosomes.
Conclusions:
- The study successfully identified novel DNA sequences and chromosome breakpoints within the 3p14-p23 region.
- These findings contribute to the identification of potential tumor suppressor genes involved in lung and renal cell carcinoma.
- The methodology is validated for isolating specific genomic regions and potential cancer-related genes.